A Message to Clinicians:

Biometric data monitoring and analysis is a cutting-edge rapidly developing segment within healthcare. A principal value of more effective biometric data monitoring and reporting is in improved support of chronic disease management as well as in primary care.

Clinical interpretation of UDW data occurs by the licensed medical provider or licensed clinician, and their interpretation can prompt action or intervention. UDWs internal analytic process displays variance that may or may not be clinically significant. The clinician provides all diagnostic interpretation and determines if and when communication or clinical intervention is warranted.

UDW strives to advance the field of clinical analytics across targeted populations of patients with the goal of improving healthcare outcomes for individuals suffering from chronic diseases. Examples include Substance Use Disorder (Addiction), Obesity, Diabetes, Congestive Heart Failure, Cardiac Arrythmia and include other opportunities to support patients or populations with high-risk medications, gait instability with risk for falls, or medication non-compliance with a history of clinical decompensation.

Dr. Andrew Mendenhall M.D.

• Fellowship in Clinical Leadership at OHSU
• Oregon Health & Science University; MD; Family Medicine Residency
• Board certified: American Board of Addiction Medicine and American Board of Family Medicine
• Diplomate of the American Academy of Pain Management.